For instance, inhibiting pyruvate dehydrogenase kinase (PDK) can enhance TCA activity, promote acetyl-CoA production, and lead to increased histone acetylation, thereby boosting PD-L1 expression on tumor cells (67). The gene discussed is CD274; the disease is neoplasm.